Total offers pharma processing and packaging solutions
Interphex Hub will stage series of free seminars with top industry speakers
Further highlights will be a series of dedicated free-to-attend seminars in both the Packaging Innovation and Interphex hubs.
Top pharmaceutical companies and specialist equipment suppliers have been confirmed as speakers for the Interphex Hub seminars. Leading names taking part in the seminar programme, sponsored by Bürkert Fluid Control Systems and chaired by Mike Warren, formerly of Niro Pharma, include GlaxoSmithKline, R5 Pharmaceuticals, Atacama Labs, Upperton, Oystar Manesty, Cognex, Hapa and Pharma Tech.
Taking place over the three days of the show, topics will include anticounterfeiting and mass serialisation, Track & Trace technologies, 2D data matrix codes, new technologies for formulation development and GMP manufacture, and a new system for the online monitoring of tablet coating thickness.
‘As a strong Reed Exhibitions brand known around the world, Interphex offers the ideal platform for companies to demonstrate their latest solutions to a wide variety of packaging and production challenges,’ said Ian Crawford, Group Exhibition Director. ‘The seminar programme is an excellent focal point for the Hub and promises to deliver some very interesting presentations and stimulating debates.’
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
Upcoming event
You may also like
Manufacturing
Drug-loaded pellets: unlocking flexible oral dosage design with modern pelletisation technologies
Produced using advanced extrusion–spheronisation technologies such as GEA’s NICA systems, drug-loaded pellets are gaining traction as a flexible and scalable oral solid dosage platform that enhances release control, patient outcomes and manufacturing efficiency
Manufacturing
Vetter Pharma to build new manufacturing site in Germany as part of €1.5bn global expansion plan
The company has submitted a building permit application for a new commercial manufacturing facility in Saarland, Germany, with construction set to begin in Q2 2026 and operations planned for 2031